ClinicalTrials.gg
Status unknownNCT01454492AR-GTUpdated Oct 19, 2011

The Relationship Between Allergic Rhinitis and Geographic Tongue

An observational study in Allergic Rhinitis and Geographic Tongue, sponsored by China Medical University Hospital. Status unknown at 1 site in Taiwan. Open to participants aged 20 Years to 89 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2011-10-19.

Sponsored by China Medical University Hospital · Observational

The sponsor has not verified this record recently (last verified Oct 2011), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
300
Ages
20 Years to 89 Years
Sex
All
01

Study summary

Allergic rhinitis is a complex chronic inflammatory disease, it always presents with nasal obstruction, nasal itching, sneezing and runny nose. Whether in adults or children, rhinitis is a complex disease. The prevalence of allergic rhinitis in Taiwan is about 24-29%. Taiwan is a developing country. It is a hot and humid country. In developing countries, industrialization, air pollution makes the constantly increasing number of patients with rhinitis. Penghu in 1994 for children aged 7 to 14 by the study found that among 7599 people, 1766 people have allergic rhinitis, about 23.2%. Allergic rhinitis is a complex chronic disease. So, it become a diagnostic challenge, its prevalence always underestimated. The prevalence of rhinitis has increased in recent years. The phenomenon of underestimate is caused by variety of personal and environmental factors. Allergic rhinitis had increased direct and indirect social and economic burden.

Geographic tongue is a benign tongue performance. Geographic tongue has been reported their relevance to allergy. Geographic tongue is a chronic tongue situation. The causes of geographic tongue still remains unknown. Allergic rhinitis is a diagnostic challenge to clinicians. The investigators hope that geographic tongue could play a role in the diagnostic of allergic rhinitis. The prevalence of geographic tongue in the United States is about 1.8%, white Americans and Mexicans have a higher incidence rate. This study will investigate the relevance between allergic rhinitis and geographic tongue. The investigators will analyze the relevant gender, age, severity of inspection reports. The research results wound provide an important reference to the diagnosis of allergic rhinitis.

02

Conditions studied

  • Allergic Rhinitis
  • Geographic Tongue

Keywords

  • Allergy rhinitis
  • Geographic tongue
03

In context

Rhinitis, Allergic

717 studies on the registry are indexed under Rhinitis, Allergic; 94 are open to participants now.

This study's planned enrollment of 300 is above the median of 120 across 143 observational studies indexed under Rhinitis, Allergic.

Browse Rhinitis, Allergic studies →

Lead sponsor

China Medical University Hospital is the lead sponsor of 479 studies on the registry; 115 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 89 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Group 1: Allergy rhinitis Group 2: Non-allergy rhinitis

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • rhinitis and non-rhinitis patients
  • willing to complete the study
  • no limitation of tongue movement

Exclusion criteria

Exclusion Criteria:

  • more than 90 years old or younger than 20 years old
  • unable to complete the study
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
300 participants (estimated)

Groups and cohorts

  • Allergy rhinitis

    Allergy rhinitis patients group

  • Non- Allergy rhinitis

    Non- Allergy rhinitis patients group

06

What researchers measure

Primary outcomes

  1. Number of participants with Adverse Events

    Time frame: 8th month

07

Study locations

1 of 1 sites recruiting
  • China Medical University Hospital
    Taichung, 404, Taiwan
    Recruiting
08

References and documents

Publications

  • Miloglu O, Goregen M, Akgul HM, Acemoglu H. The prevalence and risk factors associated with benign migratory glossitis lesions in 7619 Turkish dental outpatients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Feb;107(2):e29-33. doi: 10.1016/j.tripleo.2008.10.015. PubMed 19138635 ↗
  • Reamy BV, Derby R, Bunt CW. Common tongue conditions in primary care. Am Fam Physician. 2010 Mar 1;81(5):627-34. PubMed 20187599 ↗
  • Masferrer E, Jucgla A. Images in clinical medicine. Geographic tongue. N Engl J Med. 2009 Nov 12;361(20):e44. doi: 10.1056/NEJMicm0810145. No abstract available. PubMed 19907039 ↗
  • Shulman JD, Carpenter WM. Prevalence and risk factors associated with geographic tongue among US adults. Oral Dis. 2006 Jul;12(4):381-6. doi: 10.1111/j.1601-0825.2005.01208.x. PubMed 16792723 ↗
  • Ugar-Cankal D, Denizci S, Hocaoglu T. Prevalence of tongue lesions among Turkish schoolchildren. Saudi Med J. 2005 Dec;26(12):1962-7. PubMed 16380783 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 19, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01454492
Responsible party
Sponsor
First posted
Oct 19, 2011
Start date
Sep 2011
Primary completion
Mar 2012 (estimated)
Completion
Sep 2012 (estimated)
Last update
Oct 19, 2011

Study contacts

CJ Tai, M.D.
principal investigator · China Medical University Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion